GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (NEOE:BMND) » Definitions » EV-to-EBITDA

Biomind Labs (NEOE:BMND) EV-to-EBITDA

: -14.42 (As of Today)
View and export this data going back to 2021. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Biomind Labs's enterprise value is C$27.86 Mil. Biomind Labs's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was C$-1.93 Mil. Therefore, Biomind Labs's EV-to-EBITDA for today is -14.42.

The historical rank and industry rank for Biomind Labs's EV-to-EBITDA or its related term are showing as below:

NEOE:BMND' s EV-to-EBITDA Range Over the Past 10 Years
Min: -30.33   Med: 0   Max: 11.97
Current: -14.42

During the past 2 years, the highest EV-to-EBITDA of Biomind Labs was 11.97. The lowest was -30.33. And the median was 0.00.

NEOE:BMND's EV-to-EBITDA is ranked worse than
100% of 471 companies
in the Biotechnology industry
Industry Median: 9.01 vs NEOE:BMND: -14.42

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-20), Biomind Labs's stock price is C$0.375. Biomind Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was C$-0.045. Therefore, Biomind Labs's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Biomind Labs EV-to-EBITDA Historical Data

The historical data trend for Biomind Labs's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomind Labs Annual Data
Trend Dec21 Dec22
EV-to-EBITDA
-18.36 -16.84

Biomind Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.53 -16.84 -9.49 -8.74 -11.52

Competitive Comparison

For the Biotechnology subindustry, Biomind Labs's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomind Labs EV-to-EBITDA Distribution

For the Biotechnology industry and Healthcare sector, Biomind Labs's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Biomind Labs's EV-to-EBITDA falls into.



Biomind Labs EV-to-EBITDA Calculation

Biomind Labs's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=27.858/-1.932
=-14.42

Biomind Labs's current Enterprise Value is C$27.86 Mil.
Biomind Labs's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomind Labs  (NEOE:BMND) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Biomind Labs's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.375/-0.045
=At Loss

Biomind Labs's share price for today is C$0.375.
Biomind Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.045.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Biomind Labs EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Biomind Labs's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomind Labs (NEOE:BMND) Business Description

Traded in Other Exchanges
Address
Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.

Biomind Labs (NEOE:BMND) Headlines

No Headlines